Submitted by Anonymous (not verified) on 24 April 2025 - 14:00
Human medicines European public assessment report (EPAR): Kisqali, ribociclib, Date of authorisation: 22/08/2017, Revision: 21, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Kisqali, ribociclib, Date of authorisation: 22/08/2017, Revision: 21, Status: Authorised